Your browser doesn't support javascript.
loading
Antihypertension Nanoblockers Increase Intratumoral Perfusion of Sequential Cytotoxic Nanoparticles to Enhance Chemotherapy Efficacy against Pancreatic Cancer.
Bian, Suchen; Dong, Haijiang; Zhao, Long; Li, Zequn; Chen, Jian; Zhu, Xingxin; Qiu, Nasha; Jia, Xing; Song, Wenfeng; Li, Zekuan; Zheng, Shusen; Wang, Hangxiang; Song, Penghong.
Afiliação
  • Bian S; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Dong H; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, 310003, China.
  • Zhao L; Key Laboratory of the diagnosis and treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Hangzhou, 310003, China.
  • Li Z; Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Hangzhou, Zhejiang Province, 310003, China.
  • Chen J; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Zhu X; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, 310003, China.
  • Qiu N; Key Laboratory of the diagnosis and treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Hangzhou, 310003, China.
  • Jia X; Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Hangzhou, Zhejiang Province, 310003, China.
  • Song W; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
  • Li Z; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, 310003, China.
  • Zheng S; Key Laboratory of the diagnosis and treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Hangzhou, 310003, China.
  • Wang H; Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Hangzhou, Zhejiang Province, 310003, China.
  • Song P; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Adv Sci (Weinh) ; 9(29): e2201931, 2022 10.
Article em En | MEDLINE | ID: mdl-36026578
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Pró-Fármacos / Carcinoma Ductal Pancreático / Nanopartículas / Antineoplásicos Limite: Animals Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Pró-Fármacos / Carcinoma Ductal Pancreático / Nanopartículas / Antineoplásicos Limite: Animals Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China